These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3976757)

  • 1. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate.
    Yemini M; Borenstein R; Dreazen E; Apelman Z; Mogilner BM; Kessler I; Lancet M
    Am J Obstet Gynecol; 1985 Mar; 151(5):574-7. PubMed ID: 3976757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population.
    Hauth JC; Gilstrap LC; Brekken AL; Hauth JM
    Am J Obstet Gynecol; 1983 May; 146(2):187-90. PubMed ID: 6682631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor.
    Johnson JW; Austin KL; Jones GS; Davis GH; King TM
    N Engl J Med; 1975 Oct; 293(14):675-80. PubMed ID: 1099445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.
    Meis PJ; Klebanoff M; Thom E; Dombrowski MP; Sibai B; Moawad AH; Spong CY; Hauth JC; Miodovnik M; Varner MW; Leveno KJ; Caritis SN; Iams JD; Wapner RJ; Conway D; O'Sullivan MJ; Carpenter M; Mercer B; Ramin SM; Thorp JM; Peaceman AM; Gabbe S;
    N Engl J Med; 2003 Jun; 348(24):2379-85. PubMed ID: 12802023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
    Hartikainen-Sorri AL; Kauppila A; Tuimala R
    Obstet Gynecol; 1980 Dec; 56(6):692-5. PubMed ID: 7443111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: a comparison with ritodrine.
    Kauppila A; Hartikainen-Sorri AL; Jänne O; Tuimala R; Järvinen PA
    Am J Obstet Gynecol; 1980 Oct; 138(4):404-8. PubMed ID: 7424996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
    Saghafi N; Khadem N; Mohajeri T; Shakeri MT
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1342-5. PubMed ID: 21564406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk prematurity--progestin treatment and steroid studies.
    Johnson JW; Lee PA; Zachary AS; Calhoun S; Migeon CJ
    Obstet Gynecol; 1979 Oct; 54(4):412-8. PubMed ID: 492618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system.
    Manuck TA; Stoddard GJ; Fry RC; Esplin MS; Varner MW
    Am J Obstet Gynecol; 2016 Nov; 215(5):622.e1-622.e8. PubMed ID: 27418444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in the prevention of premature labor, and its effect upon fetal salvage.
    EICHNER E
    Ann N Y Acad Sci; 1958 Jul; 71(5):787-93. PubMed ID: 13583833
    [No Abstract]   [Full Text] [Related]  

  • 11. 17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial.
    Combs CA; Garite TJ; Maurel K; Abril D; Das A; Clewell W; Heyborne K; How H; Huang W; Lewis D; Lu G; Miller H; Nageotte M; Porreco R; Sheikh A; Tran L;
    Am J Obstet Gynecol; 2015 Sep; 213(3):364.e1-12. PubMed ID: 25979614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
    Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17-α hydroxyprogesterone caproate for the prevention of preterm birth.
    Gupta S; Roman AS
    Womens Health (Lond); 2012 Jan; 8(1):21-30. PubMed ID: 22171770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
    Odibo AO; Stamilio DM; Macones GA; Polsky D
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):492-9. PubMed ID: 16946206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent hope for the treatment of preterm delivery.
    Doggrell SA
    Expert Opin Pharmacother; 2003 Dec; 4(12):2363-6. PubMed ID: 14640934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Meis PJ; Klebanoff M; Dombrowski MP; Sibai BM; Leindecker S; Moawad AH; Northen A; Iams JD; Varner MW; Caritis SN; O'Sullivan MJ; Miodovnik M; Leveno KJ; Conway D; Wapner RJ; Carpenter M; Mercer B; Ramin SM; Thorp JM; Peaceman AM; Gabbe S
    Obstet Gynecol; 2005 Sep; 106(3):557-61. PubMed ID: 16135587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity.
    Awwad J; Usta IM; Ghazeeri G; Yacoub N; Succar J; Hayek S; Saasouh W; Nassar AH
    BJOG; 2015 Jan; 122(1):71-9. PubMed ID: 25163819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographically short cervix: A randomized controlled trial.
    Pirjani R; Heidari R; Rahimi-Foroushani A; Bayesh S; Esmailzadeh A
    J Obstet Gynaecol Res; 2017 Jan; 43(1):57-64. PubMed ID: 27775195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report.
    Ng KS; Ng BK; Lim PS; Shafiee MN; Abdul Karim AK; Omar MH
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):89-91. PubMed ID: 26684353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the efficiency of hydroxyprogesterone caproate and of chlormadinone acetate in the prevention of premature labor.
    Bréart G; Lanfranchi M; Chavigny C; Rumeau-Rouquette C; Sureau C
    Int J Gynaecol Obstet; 1979; 16(5):381-4. PubMed ID: 86468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.